Skip to main content

Peer Review reports

From: A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis

Original Submission
23 Sep 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Nov 2022 Reviewed Reviewer Report
2 Dec 2022 Reviewed Reviewer Report
18 Dec 2022 Author responded Author comments - Xinyu Yang
Resubmission - Version 3
18 Dec 2022 Submitted Manuscript version 3
20 Jan 2023 Author responded Author comments - Xinyu Yang
Resubmission - Version 4
20 Jan 2023 Submitted Manuscript version 4
7 Feb 2023 Author responded Author comments - Xinyu Yang
Resubmission - Version 5
7 Feb 2023 Submitted Manuscript version 5
9 Feb 2023 Author responded Author comments - Xinyu Yang
Resubmission - Version 6
9 Feb 2023 Submitted Manuscript version 6
Publishing
23 Feb 2023 Editorially accepted
3 Mar 2023 Article published 10.1186/s12896-023-00776-8

You can find further information about peer review here.

Back to article page